Evidence map›Paper›PMID 31993371›Full record

ArticleFrontiers in oncology2019

N

Giovanna Navarra, Cristina Pagano, Roberto Pacelli, Elvira Crescenzi, Elena Longobardi, Patrizia Gazzerro, Donatella Fiore, Olga Pastorino, Francesca Pentimalli, Chiara Laezza and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Preliminary screening and correlation analysis for lncRNAs related to radiosensitivity in melanoma cells by inhibiting glycolysis.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2021
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Giovanna NavarraDepartment of Molecular Medicine and Medical Biotechnology, University of Naples "Federico II," Naples, Italy.
Cristina PaganoDepartment of Molecular Medicine and Medical Biotechnology, University of Naples "Federico II," Naples, Italy.
Roberto PacelliDepartment of Advanced Biomedical Sciences, Federico II University School of Medicine, Naples, Italy.
Elvira CrescenziInstitute of Endocrinology and Experimental Oncology, Institute of Endocrinology and Experimental Oncology (IEOS), National Research Council (CNR), Naples, Italy.
Elena LongobardiSection of Pharmacology, Department of Neuroscience University of Naples Federico II, Naples, Italy.
Patrizia GazzerroDepartment of Pharmacy, University of Salerno, Naples, Italy.
Donatella FioreDepartment of Pharmacy, University of Salerno, Naples, Italy.
Olga PastorinoDepartment of Molecular Medicine and Medical Biotechnology, University of Naples "Federico II," Naples, Italy.
Francesca PentimalliCell Biology and Biotherapy Unit, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Naples, Italy.
Chiara LaezzaInstitute of Endocrinology and Experimental Oncology, Institute of Endocrinology and Experimental Oncology (IEOS), National Research Council (CNR), Naples, Italy.
Maurizio BifulcoDepartment of Molecular Medicine and Medical Biotechnology, University of Naples "Federico II," Naples, Italy.
University of Naples Federico II · ITUniversity of Salerno · ITFederico II University Hospital · ITInstitute for Experimental Endocrinology and Oncology · ITIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · ITNational Research Council · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma is among the most common malignant brain tumors and has a dismal prognosis due to the poor response to therapeutic regimens such as ionizing radiation and DNA-alkylating agents. In our study, we investigated the radiosensitizing activity of the N

Indexed as

apoptosisglioblastoma cellsiPARAD51STAT5a/b

Identifiers

PMID31993371
PMCPMC6971108
OpenAlexW3000222501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.